Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
|
|
Milestone Pharmaceuticals Inc. (MIST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 06/09/2023 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 06/09/2023 |
4
| Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 06/09/2023 |
4
| Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 06/09/2023 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 06/09/2023 |
4
| Fischer Seth H. Z. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 03/24/2023 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Disposed of 1,059,000 shares
@ $0 |
|
| 03/23/2023 |
4
| Fischer Seth H. Z. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 42,000 options to buy
@ $3.45, valued at
$144.9k
|
|
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Acquired 127 shares
@ $0 |
|
| 09/09/2022 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Bought 1,557,346 shares
@ $8.71, valued at
$13.6M
Sold 1,557,346 shares
@ $8.71, valued at
$13.6M
|
|
| 08/11/2022 |
4
| Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 08/11/2022 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 08/11/2022 |
4
| Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 08/11/2022 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 08/11/2022 |
4
| Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Oliveto Joseph (President and CEO) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 500,000 options to buy
@ $5.46, valued at
$2.7M
|
|
| 03/23/2022 |
4
| Hasija Amit (CFO & EVP of Corp. Development) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 175,000 options to buy
@ $5.46, valued at
$955.5k
|
|
| 03/23/2022 |
4
| Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 160,000 options to buy
@ $5.46, valued at
$873.6k
|
|
| 02/17/2022 |
4
| Bharucha David (Chief Medical Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 330,000 options to buy
@ $6.47, valued at
$2.1M
|
|
| 07/29/2021 |
4
| TRUEX PAUL F (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 07/29/2021 |
4
| TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 07/29/2021 |
4
| Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 07/29/2021 |
4
| Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 07/29/2021 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 07/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Plat Francis (Chief Medical Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 130,000 options to buy
@ $6.26, valued at
$813.8k
|
|
|
|
|